Kal

Tri-Zinc 50

D
N+ Score62
Vitamins & MineralsServing: 1 Tablet(s)Type: Mineral

Kal's Tri-Zinc 50 is a focused 'Mineral' supplement, providing a single active ingredient. Each tablet delivers 50mg of Zinc, which is considered a clinically studied dosage for individuals requiring significant zinc supplementation. The product demonstrates excellent label transparency at 100% and achieves an N+ Score of 62, earning a D grade, largely due to its formula completeness score of 0% given it's a single-ingredient product. Its ingredient adequacy, however, is 100% for its sole active compound. This supplement is ideal for individuals specifically looking to supplement with a high dose of zinc, without additional ingredients.

About This Product

Tri-Zinc 50 by Kal is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 62/100 (Grade D).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Zinc.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category
  • Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Zinc50.000 mgHigh

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.